VMBIP Newsletter – October 17, 2008

VMBIP Updates

•	Due to larger than normal ordering patterns nationwide, McKesson has many orders in the queue.  In an effort to clear the queue as soon as possible, McKesson will ship both flu and non-flu orders on Saturday, October 18, for delivery to providers with open hours on Monday, October 20. 

•	On October 22 and 23, 2008, the VTrckS External Information System (ExIS) Blueprint Phase Workgroup is meeting in Atlanta.  The purpose of this meeting is to identify the content of electronic messages that is needed to support grantee VFC program operations.  The workgroup will create a message content specification document that will be approved by the Grantee Advisory Committee for submission to VTrckS project team.  The workgroup members include 12 grantees and CDC staff and consultants.  If you have any comments, suggestions, or questions you would like brought to the table at this meeting, please forward them to Barbara Laymon at BLLaymon@cdc.gov. 

•	Due to seasonal weather changes across the country, McKesson has modified the pack-out for vaccine shipments.  Your providers may notice some slight changes to the way in which their vaccine shipments are packed. 

•	The Fluvirin Novartis .5ml Luer Lock single dose pre-filled syringe 66521-0111-02 is now available for provider orders only through the non-Federal VACMAN ordering screen for those grantees that have ordered outside the federal contracts.  Once the doses have arrived at McKesson you can use the non-Federal ordering screen to place your provider orders.  The daily allocation report will not provide any information on the Luer Lock because of the necessity to use the non-Federal screen in VACMAN

VMBIP Performance Dashboard

WEEKLY PERFORMANCE METRIC SCORECARD

A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 09-26-08:   69.1 percent
Week Ending 10-03-08:   86.4 percent
Week Ending 10-10-08:   87.6 percent
Weighted Average Last 3 Weeks: 83.5 percent
Explanation:  9/26 CDC: Grantees requested orders to be held due to hurricanes as well as other weather related issues.  Many of those orders were released and 
shipped during the weeks ending 9/26 – grantees requesting held orders were removed from the calculation.

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 09-26-08:   99.3 percent
Week Ending 10-03-08:   97.2 percent
Week Ending 10-10-08:   98.7 percent
Weighted Average Last 3 Weeks: 98.3 percent
Explanation:  None

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending 09-26-08:   99.98 percent
Week Ending 10-03-08:   100 percent
Week Ending 10-10-08:   100 percent
Weighted Average Last 3 Weeks: 99.99 percent
Explanation:  None

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending 09-26-08:   98.34 percent
Week Ending 10-03-08:   98.90 percent
Week Ending 10-10-08:   99.86 percent
Weighted Average Last 3 Weeks: 99.16 percent
Explanation:  None

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending 09-26-08:   100 percent
Week Ending 10-03-08:   100 percent
Week Ending 10-10-08:   100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending 09-26-08:   99 percent
Week Ending 10-03-08:   100 percent
Week Ending 10-10-08:   n/a
Weighted Average Last 3 Weeks:  n/a 
Explanation:  9/26 McK: 1 DTAP and 1 Flu receipt were outside of the specified metrics.

F
Metric: State Funded PO Transmission
Week Ending 09-26-08:   100 percent
Week Ending 10-03-08:   n/a
Week Ending 10-10-08:   84 percent
Weighted Average Last 3 Weeks:  91 percent
Explanation: 10/3 McK and CDC: 1 flu order was received outside of the 24 hour period and 1 order was delayed due to McK not receiving the State/317 Excel file
10/10 McK: 6 orders were received but the receipt info was not transmitted in the required time. 

Key
A. Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		

B. Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)
	
C1. Percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable/customer not available, or carrier damageC2. Percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address/delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 

D.  Percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	

E.  Percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) / 48 (other) hrs of delivery by manufacturer	

F.  Percent of grantee replenishment orders McKesson faxes/e-mails receipt to grantees within 48 hrs of delivery by manufacturer

Vaccines on allocation HIB and FLU; Vaccines on manufacturer shortage Merck Hep A.  Vaccines placed on backorder during the most recent week: DTAP (6110 doses) – orders placed but not received; HEP A (15200 doses) – product received day after backorders created; HEP AB (225 doses) – large orders reduced inventory, orders placed but not yet received; HEP B –A (120 doses) larger orders reduced inventory, orders placed but not yet received; HEP B-PF 

(3385 doses) – orders placed but not yet received; MMR (80 doses) – systems issue; PNU 7 (500 doses) – systems issue; ROTA (13690 doses) – order placed but not yet received; TD (1750 doses) – large orders depleted inventory and new orders will be placed; TDAP (3830 doses) – orders placed but not yet received 

VMBIP Performance Dashboard – Shipping Metrics by Distribution Center
Weekly Performance Metric Scorecard

Memphis (8578)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 09-26-08:   59.2 percent
Week Ending 10-03-08:   80.8 percent
Week Ending 10-10-08:   82.3 percent
Weighted Average Last 3 Weeks: 76.8 percent
Explanation:  9/26: NC, LA, MS, KY, OH, & FL requested that orders be held due to hurricane/weather concerns – all NC, LA, MS, KY, OH, & FL orders were removed from the calculation.

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 09-26-08:   99.1 percent
Week Ending 10-03-08:   97.2 percent
Week Ending 10-10-08:   98.4 percent
Weighted Average Last 3 Weeks: 98.2 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 09-26-08:   98.5 percent
Week Ending 10-03-08:   96.8 percent
Week Ending 10-10-08:   98.6 percent
Weighted Average Last 3 Weeks: 97.9 percent
Explanation:  9/26: TX requested that orders be held due to hurricane/weather concerns – all TX orders were removed from the calculation.

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 09-26-08:   100 percent
Week Ending 10-03-08:   97.1 percent
Week Ending 10-10-08:   99.3 percent

Weighted Average Last 3 Weeks:  98.5 percent 
Explanation:  none

Key
A. Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation) - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		

B. Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)

As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/downloads/newsletters/vmbip-nl-10-17-08.rtf